ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
78.51
-2.60 (-3.21%)
At close: May 29, 2026, 4:00 PM EDT
78.55
+0.04 (0.05%)
After-hours: May 29, 2026, 5:40 PM EDT
ANI Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 311.18 | 285.59 | 144.86 | 221.12 | 48.23 | 100.3 |
Short-Term Investments | 14.89 | 9.13 | 6.31 | - | - | - |
Cash & Short-Term Investments | 326.06 | 294.72 | 151.17 | 221.12 | 48.23 | 100.3 |
Cash Growth | 110.11% | 94.96% | -31.64% | 358.49% | -51.92% | 1175.43% |
Accounts Receivable | 255.43 | 281.08 | 221.73 | 162.08 | 165.44 | 128.53 |
Inventory | 143.47 | 143.07 | 136.78 | 111.2 | 105.36 | 81.69 |
Other Current Assets | 22.12 | 34.25 | 18.01 | 25.42 | 25.24 | 11.26 |
Total Current Assets | 747.08 | 753.12 | 527.68 | 519.82 | 344.26 | 321.78 |
Net Property, Plant & Equipment | 67.12 | 62.48 | 56.86 | 44.59 | 43.25 | 52.67 |
Other Intangible Assets | 467.16 | 479.53 | 541.83 | 209.01 | 251.64 | 294.12 |
Goodwill | 62.48 | 62.48 | 59.99 | 28.22 | 28.22 | 27.89 |
Other Long-Term Assets | 78.13 | 82.78 | 97.33 | 102.78 | 92.72 | 75.14 |
Total Assets | 1,422 | 1,440 | 1,284 | 904.42 | 760.09 | 771.6 |
Accounts Payable | 69.69 | 62.58 | 45.66 | 36.68 | 29.31 | 22.97 |
Accrued Expenses | 102.17 | 146.52 | 92.8 | 57.84 | 35.89 | 27.89 |
Short-Term Debt | 19.3 | 17.27 | 9.17 | 0.85 | 0.85 | 0.83 |
Other Current Liabilities | 48.35 | 51.74 | 46.05 | 50.11 | 33.4 | 35.83 |
Total Current Liabilities | 239.51 | 278.11 | 193.68 | 145.48 | 99.44 | 87.54 |
Long-Term Debt | 594.46 | 599.77 | 614.92 | 284.82 | 285.67 | 286.52 |
Other Long-Term Liabilities | 25.7 | 21.77 | 46.57 | 16.53 | 36.44 | 38.8 |
Total Long-Term Liabilities | 620.16 | 621.54 | 661.49 | 301.35 | 322.11 | 325.32 |
Total Liabilities | 859.67 | 899.65 | 855.17 | 446.82 | 421.55 | 412.86 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | -53 | -33.25 | -21.04 | -10.08 | -5.09 | -3.14 |
Additional Paid-in Capital | 608.43 | 596.04 | 519.65 | 514.1 | 403.9 | 387.84 |
Accumulated Other Comprehensive Income | 0.48 | 1.03 | 5.34 | 8.86 | 12.17 | -3.06 |
Retained Earnings | 6.39 | -23.1 | -100.28 | -80.13 | -97.29 | -47.77 |
Total Common Shareholders' Equity | 562.3 | 540.72 | 403.68 | 432.75 | 313.69 | 333.89 |
Minority Interest | - | - | 24.85 | 24.85 | 24.85 | 24.85 |
Shareholders' Equity | 562.3 | 540.72 | 428.53 | 457.6 | 338.54 | 358.74 |
Total Liabilities & Equity | 1,422 | 1,440 | 1,284 | 904.42 | 760.09 | 771.6 |
Total Debt | 613.76 | 617.04 | 624.09 | 285.67 | 286.52 | 287.35 |
Net Cash (Debt) | -287.7 | -322.32 | -472.92 | -64.55 | -238.29 | -187.05 |
Net Cash Per Share | -13.75 | -15.18 | -24.48 | -3.55 | -14.65 | -14.93 |
Book Value | 562.3 | 540.72 | 403.68 | 432.75 | 313.69 | 333.89 |
Book Value Per Share | 26.87 | 25.47 | 20.90 | 23.79 | 19.29 | 26.65 |
Tangible Book Value | 32.66 | -1.28 | -198.14 | 195.52 | 33.83 | 11.88 |
Tangible Book Value Per Share | 1.56 | -0.06 | -10.26 | 10.75 | 2.08 | 0.95 |